|
Inhibition of the mFAO exacerbates proteostasis impairment in atrophic zebrafish. (a) Western blot and quantification of poly-ubiquitinated proteins in the detergent-soluble and -insoluble fractions of the protein lysates from larval zebrafish treated with DEXA(S) and/or ETO (DEXA(S) indicates a short-course treatment. *p < 0.05, t-test, two-tailed, error bar indicates s.d.). (b) qRT-PCR analysis of zebrafish larvae treated with DEXA(S) and/or ETO showing the expression of the proteostasis genes hsp70.1 and sqstm1 (*p < 0.05, t-test, two-tailed, error bar indicates s.d.). (c) Left: schematic illustration of the hormesis treatment. Right: qPCR analysis of zebrafish treated with DEXA(S)+ETO with or without the hormesis treatment showing the expression of the atrophy genes fbxo32 and trim63a (*p < 0.05, t-test, two-tailed, error bar indicates s.d.).
|